|
|||||
|
|
High-density lipoprotein-mediated cardioprotection in heart failure |
|
| Authors: | Jackson Ampadu O. Meng Jun Tang Huifang Yin Kai |
| Affiliation: | 1.Center for Diabetic Systems Medicine, Guangxi Key Laboratory of Excellence, Guilin Medical University, Guilin, 541100, Guangxi, China ;2.International College, University of South China, Hengyang, Hunan Province, China ;3.Functional Department, The First Affiliated Hospital of University of South China, Hengyang, 421001, Hunan, China ;4.Department of Cardiology, The First Affiliated Hospital of University of South China, Hengyang, Hunan Province, China ;5.College of General Practitioners, The Second Affiliated Hospital of Guilin Medical University, Guilin, 541100, Guangxi, China ; |
| Abstract: | The prevalence of heart failure (HF), including reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF), has increased significantly worldwide. However, the prognosis and treatment of HF are still not good. Recent studies have demonstrated that high-density lipoprotein (HDL) plays an important role in cardiac repair during HF. The exact role and mechanism of HDL in the regulation of HF remain unexplained. Here, we discuss recent findings regarding HDL in the progression of HF, such as the regulation of excitation-contraction coupling, energy homeostasis, inflammation, neurohormone activation, and microvascular dysfunction. The effects of HDL on the regulation of cardiac-related cells, such as endothelial cells (ECs), cardiomyocytes (CMs), and on cardiac resident immune cell dysfunction in HF are also explained. An in-depth understanding of HDL function in the heart may provide new strategies for the prevention and treatment of HF. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |